Skip to main content
XRAY
NASDAQ Industrial Applications And Services

Dentsply Sirona Reports Q1 Adjusted EPS Decline, Reaffirms Full-Year Outlook Amidst Transformation

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
7
Price
$11.92
Mkt Cap
$2.278B
52W Low
$9.85
52W High
$17.18
Market data snapshot near publication time

summarizeSummary

Dentsply Sirona announced Q1 2026 financial results, reporting a GAAP net loss and a 39% decrease in adjusted EPS year-over-year, but maintained its full-year financial outlook.


check_boxKey Events

  • Q1 Adjusted EPS Declined Significantly

    The company reported adjusted diluted earnings per share of $0.27 for Q1 2026, a 39.0% decrease compared to $0.44 in Q1 2025. GAAP net loss per share was ($0.05) for the quarter, down from $0.10 earnings per share in the prior year.

  • Net Sales Remained Flat

    Net sales for the first quarter of 2026 were $880 million, a marginal 0.1% increase from $879 million in the same period last year.

  • Full-Year Outlook Reaffirmed

    Dentsply Sirona reiterated its 2026 outlook, maintaining expectations for net sales in the range of $3.5 billion to $3.6 billion and adjusted EPS between $1.40 and $1.50.

  • Operating Cash Flow Improved

    Operating cash flow for Q1 2026 was $40 million, a notable improvement from $7 million in Q1 2025, primarily due to favorable collections on accounts receivable.


auto_awesomeAnalysis

Dentsply Sirona reported a significant 39% year-over-year decline in adjusted earnings per share for the first quarter, alongside a GAAP net loss. While net sales remained flat, the substantial drop in profitability indicates ongoing challenges. However, the company's decision to reiterate its full-year net sales and adjusted EPS outlook suggests management anticipates a recovery or that Q1 results were within their internal expectations for the year. Investors will be watching for signs of momentum building in subsequent quarters as the company executes its 'Return-to-Growth Action Plan' and leverages new product launches and distribution agreements.

At the time of this filing, XRAY was trading at $11.92 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $9.85 to $17.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed XRAY - Latest Insights

XRAY
May 05, 2026, 4:50 PM EDT
Filing Type: 10-Q
Importance Score:
9
XRAY
May 05, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
XRAY
May 05, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
XRAY
Apr 23, 2026, 4:32 PM EDT
Filing Type: DEF 14A
Importance Score:
8
XRAY
Mar 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
XRAY
Mar 03, 2026, 7:12 PM EST
Filing Type: 4
Importance Score:
7
XRAY
Feb 26, 2026, 5:58 PM EST
Source: Dow Jones Newswires
Importance Score:
8
XRAY
Feb 26, 2026, 5:06 PM EST
Source: dpa-AFX
Importance Score:
8
XRAY
Feb 26, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
8
XRAY
Feb 26, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8